Zim Laboratories Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
BSE Code : 541400 |
NSE Symbol : ZIMLAB |
P/E(TTM) : 30.76 |
ISIN Demat : INE518E01015 |
Div & Yield% : - |
EPS(TTM) : 3.62 |
Book Value(₹) : 47.60 |
Market Cap(₹Cr) : 542.56 |
Face Value(₹) : 10.00 |
Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|---|
Gross Sales | 82.00 | 117.39 | 95.82 | 85.26 | 67.01 | 104.45 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 82.00 | 117.39 | 95.82 | 85.26 | 67.01 | 104.45 |
Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income | 0.98 | 1.53 | 1.11 | 1.42 | 0.63 | 0.70 |
Total Income | 82.98 | 118.92 | 96.93 | 86.68 | 67.64 | 105.15 |
Total Expenditure | 74.13 | 101.96 | 84.64 | 76.30 | 62.47 | 89.40 |
PBIDT | 8.86 | 16.96 | 12.28 | 10.38 | 5.17 | 15.75 |
Interest | 2.86 | 2.28 | 1.70 | 1.22 | 1.73 | 1.27 |
PBDT | 6.00 | 14.68 | 10.59 | 9.17 | 3.44 | 14.48 |
Depreciation | 4.92 | 3.87 | 3.58 | 3.72 | 3.66 | 4.58 |
Tax | 0.21 | -1.29 | 1.30 | 0.82 | 0.00 | 1.62 |
Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 0.12 | 4.20 | 0.88 | 0.45 | -0.08 | 1.14 |
Reported Profit After Tax | 0.76 | 7.89 | 4.83 | 4.18 | -0.14 | 7.14 |
Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adjusted Profit After Extra-ordinary item | 0.76 | 7.89 | 4.83 | 4.18 | -0.14 | 7.14 |
EPS (Unit Curr.) | 0.16 | 1.62 | 0.99 | 0.86 | -0.03 | 1.46 |
EPS (Adj) (Unit Curr.) | 0.16 | 1.62 | 0.99 | 0.86 | -0.03 | 1.46 |
Calculated EPS (Unit Curr.) | 0.16 | 1.62 | 0.99 | 0.86 | -0.03 | 1.47 |
Calculated EPS (Adj) (Unit Curr.) | 0.16 | 1.62 | 0.99 | 0.86 | -0.03 | 1.47 |
Calculated EPS (Ann.) (Unit Curr.) | 0.62 | 6.48 | 3.97 | 3.43 | -0.12 | 5.86 |
Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.62 | 6.48 | 3.97 | 3.43 | -0.12 | 5.86 |
Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity | 48.73 | 48.73 | 48.73 | 48.73 | 48.73 | 48.73 |
Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PBIDTM(%) | 10.80 | 14.45 | 12.82 | 12.17 | 7.72 | 15.08 |
PBDTM(%) | 7.32 | 12.51 | 11.05 | 10.76 | 5.13 | 13.86 |
PATM(%) | 0.93 | 6.72 | 5.04 | 4.90 | -0.21 | 6.84 |